Jane Street Group, LLC Bio Xcel Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $700,346 - $935,803	-24,100 Reduced 76.51%	7,400 $215,000
Q4 2020 Feb 17, 2021	SELL	$42.46 - $56.58 $67,936 - $90,528	-1,600 Reduced 4.83%	31,500 $1.46 Million
Q3 2020 Nov 17, 2020	SELL	$37.44 - $64.63 $1.53 Million - $2.64 Million	-40,800 Reduced 55.21%	33,100 $1.44 Million
Q2 2020 Aug 17, 2020	BUY	$17.62 - $58.71 $1.3 Million - $4.34 Million	73,900 New	73,900 $3.92 Million

3.35M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $17.4M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.